| Additional risk factors for developing nephrotoxicity following radionuclide therapy |
| Elderly age-group (> 60 years) |
| Longstanding diabetes mellitus, hypertension |
| Medical/ Surgical co-morbidities (nephrotic syndrome, congestive cardiac failure, renal insufficiency, sepsis, hypovolemia, prior nephrectomy, obstructive uropathy) |
| Nephrotoxic medications – non-steroidal anti-inflammatory drugs, aminoglycoside antibiotics etc. |
| Nephrotoxic anti-cancer medications – cisplatin, mitomycin-C, methotrexate etc. |
| Thrombotic microangiopathy |
